Integer Holdings Operating Margin 2010-2022 | ITGR

Current and historical operating margin for Integer Holdings (ITGR) over the last 10 years. The current operating profit margin for Integer Holdings as of March 31, 2022 is 10.43%.
Integer Holdings Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2022-03-31 $1.24B $0.12B 9.90%
2021-12-31 $1.22B $0.14B 11.14%
2021-09-30 $1.18B $0.14B 11.47%
2021-06-30 $1.11B $0.14B 12.83%
2021-03-31 $1.04B $0.11B 10.82%
2020-12-31 $1.07B $0.12B 11.28%
2020-09-30 $1.13B $0.12B 10.27%
2020-06-30 $1.20B $0.12B 10.18%
2020-03-31 $1.27B $0.16B 12.74%
2019-12-31 $1.26B $0.16B 12.47%
2019-09-30 $1.24B $0.17B 14.08%
2019-06-30 $1.24B $0.17B 13.66%
2019-03-31 $1.24B $0.16B 13.26%
2018-12-31 $1.21B $0.16B 12.77%
2018-09-30 $1.14B $0.14B 12.51%
2018-06-30 $1.12B $0.14B 12.28%
2018-03-31 $1.08B $0.13B 11.91%
2017-12-31 $1.14B $0.13B 11.09%
2017-09-30 $0.96B $0.12B 11.98%
2017-06-30 $1.02B $0.12B 11.36%
2017-03-31 $1.09B $0.11B 10.02%
2016-12-31 $1.08B $0.09B 8.65%
2016-09-30 $1.35B $0.07B 4.98%
2016-06-30 $1.15B $0.03B 2.71%
2016-03-31 $0.97B $0.02B 1.54%
2015-12-31 $0.80B $0.01B 1.62%
2015-09-30 $0.65B $0.04B 6.13%
2015-06-30 $0.68B $0.06B 8.11%
2015-03-31 $0.68B $0.06B 9.19%
2014-12-31 $0.69B $0.08B 11.05%
2014-09-30 $0.70B $0.07B 10.36%
2014-06-30 $0.69B $0.07B 10.56%
2014-03-31 $0.69B $0.07B 10.14%
2013-12-31 $0.66B $0.06B 9.19%
2013-09-30 $0.65B $0.05B 7.59%
2013-06-30 $0.64B $0.03B 5.32%
2013-03-31 $0.64B $0.03B 4.41%
2012-12-31 $0.65B $0.03B 3.87%
2012-09-30 $0.63B $0.04B 5.88%
2012-06-30 $0.60B $0.05B 8.00%
2012-03-31 $0.58B $0.06B 9.48%
2011-12-31 $0.57B $0.06B 10.88%
2011-09-30 $0.56B $0.07B 13.19%
2011-06-30 $0.56B $0.07B 13.31%
2011-03-31 $0.55B $0.07B 13.27%
2010-12-31 $0.53B $0.07B 12.95%
2010-09-30 $0.53B $0.04B 7.98%
2010-06-30 $0.52B $0.01B 0.96%
2010-03-31 $0.51B 0 0.00%
2009-12-31 $0.52B $0.00B 0.19%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $2.383B $1.221B
Integer Holdings Corporation manufactures and develops medical devices and components primarily for original equipment manufacturers, which depend on it to design, develop and produce intellectual property protected medical device technologies. Integer Holdings operates through two segments: Medical Sales and Non-Medical Sales. Medical Sales has three sub-segments Advanced Surgical, Orthopedics and Portable Medical; Cardio and Vascular; and Cardiac Rhythm Management & Neuromodulation.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.627B 21.80
Edwards Lifesciences (EW) United States $60.552B 42.53
Alcon (ALC) Switzerland $35.080B 30.59
STERIS (STE) Ireland $21.113B 26.67
Fresenius Medical Care AG KGaA (FMS) Germany $14.716B 13.22
Teleflex (TFX) United States $11.964B 19.12
Globus Medical (GMED) United States $5.873B 29.30
Penumbra (PEN) United States $4.736B 299.29
Glaukos (GKOS) United States $2.256B 0.00
Nevro (NVRO) United States $1.608B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.313B 23.51
Paragon 28 (FNA) United States $1.281B 0.00
Artivion (AORT) United States $0.772B 83.52